Accelerate Diagnostics Forecast and Stock Analysis
Technical AXDX stock analysis for Wednesday May 22, 2019.
|Price to book||USD 24.09|
|Next Earnings Date||2019-08-05|
Accelerate Diagnostics gained 0.68% in the last trading day ( Wednesday, 22nd May 2019 ), rising from $19.07 to $19.20 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 3.72% from a day low at $18.84 to a day high of $19.54. The price has been going up and down for this period, and there has been a -4% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 38 686 more shares were traded than the day before. In total, 182 814 shares bought and sold for approximately $3.51 million.
- 30 day high of the AXDX stock price was $20.97 and low was $17.75.
- 90 day high was $22.42 and low was $17.65.
- 52 week high for the Accelerate Diagnostics - $24.75 and low - $10.23.
Accelerate Diagnostics lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.18% during the next 3 months and, with 90% probability hold a price between $15.24 and $18.49 at the end of this period.
Accelerate Diagnostics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $19.17 and $19.10. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
Accelerate Diagnostics finds support from accumulated volume at $19.00.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.70 (3.72%) between high and low. For the last week, the stock has had a daily average volatility of 4.37%.
Our recommended stoploss: $18.03 (-6.09%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
4.37 %Average volatility
Very Low Low Medium High Very High
Accelerate Diagnostics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AXDX $19.20 ($0.13 0.68%)|
AXDX is up $0.13 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AXDX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AXDX analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us